Coenzyme Q10 - A novel molecule

Journal, Indian Academy of Clinical Medicine

Volumn 14, Issue 1, 2013, Pages 37-45

  Kapoor, Pragati ^a   Kapoor, A K ^b  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

^b ROHILKHAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Antioxidant; Coenzyme Q10

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMITRIPTYLINE; DOXEPIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; MAGNESIUM CITRATE; ORAL CONTRACEPTIVE AGENT; PLACEBO; RIBOFLAVIN; UBIDECARENONE; WARFARIN;

ALLERGIC REACTION; ANGINA PECTORIS; ANOREXIA; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD PRESSURE; BREAST CANCER; CHRONIC FATIGUE SYNDROME; CONGESTIVE HEART FAILURE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SAFETY; DRUG SYNTHESIS; ELECTRON TRANSPORT; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEART ARREST; HUMAN; HUNTINGTON CHOREA; HYPERTROPHIC CARDIOMYOPATHY; LYME DISEASE; MIGRAINE; MUSCULAR DYSTROPHY; NAUSEA; PARKINSON DISEASE; PARTICLE SIZE; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTOLIC HYPERTENSION; TOOTH DISEASE; VOMITING;

EID: 84877871264     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Tran MT, Mitchell TM, Kennedy DT et al. Role of Coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy 2001; 21: 797-808.
2. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochimica et Biophysica Acta 1995; 1271 (1): 195-204.
3. Dutton PL Ohnishi T, Darrouzet E et al. Coenzyme Q oxidation reduction reactions in mitochondrial electron transport. In Kagan VE; Quinn PJ. Coenzyme Q: Molecular mechanisms in health and disease. Boca Raton: CRC Press. 2000; pp. 65-82.
4. Bonakdar RA, Guarneri E. Coenzyme Q10. American Fam Physician 2005; 72 (6): 1065-70.
5. Crane F, Hatefi Y, Lester R et al. Isolation of a quinone from beef heart mitochondria. Biochimica et Biophysica Acta 1957; 25(1): 220-21.
6. Igor P, Katja Z, Janko Z. Coenzyme Q10 contents in foods and fortification strategies. Critical Reviews in Food Science and Nutrition 2010; 50 (4): 269-80.
7. Tran UC, Clarke CF. Endogenous synthesis of Coenzyme Q in Eukaryotes. Mitochondrion 2007; 7: S62-71.
8. Bentinger M, Tekle M, Dallner G. Coenzyme Q - Biosynthesis and functions. Biochem. Biophys Res Commun 2010; 396(1): 74-79.
9. Okamoto T, Matsuya T, Fukunaga Y et al. Human serum ubiquinol-10 levels and relationship to serum lipids. Int. J Vitamin, Nutrition Res. Internationale Zeitschrift fur Vitamin-und Ernahrungsforschung. Journal International de vitaminologie et de nutrition 1989; 59(3): 288-92.
10. Aberg F, Appelkvist EL, Dallner G et al. Distribution and redox state of ubiquinones in rat and human tissues. Archives of Biochemistry and Biophysics 1992; 295(2):230-34.
11. Sugiyama S, Kitazawa M, Ozawa T et al. Antioxidative effect of Coenzyme Q10. Experentia 1980; 36: 1002-03.
12. Ochiai A, Itagaki S, Kurokawa T et al. Improvement in intestinal coenzyme Q10 absorption by food intake. Yakugaku Zasshi 2007;127(8):1251-54.
13. Bhagavan H N, Chopra RK. Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research 2006; 40(5): 445-53.
14. Joshi SS, Sawant SV, Shedge A et al. Comparative bioavailability of two novel coenzyme Q10 preparations in humans. Int J Clin Pharmacol Ther 2003; 41(1):42-48.
15. Westesen K, Siekmann B. Particles with modified physicochemical properties, their preparation and uses. US6197349. 2001.
16. Ohashi H, Takami T, Koyama N et al. Aqueous solution containing Ubidecarenone. US4483873.1984
17. Zmitek J, Smidovnik A, Fir M et al. Relative bioavailability of two forms of a novel water-soluble CoenzymeQ10. Ann Nutri Metabol 2008; 52(4): 281-87.
18. Kagan, D, Madhavi D. A study on the bioavailability of a novel sustained-release Coenzyme Q10-ß-Cyclodextrin Complex. Integrative Medicine 2010;9(1): 20-24.
19. Tomono Y, Hasegawa J, Seki T et al. Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man. Int J Clin Pharmacol Ther Toxicol 1986;24(10): 536-41.
20. Montero R, Sanchez-Alcazar JA, Briones P et al. Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin Biochem 2008;41(9): 697-700.
21. Kishi T, Watanabe T, Folkers K. Bioenergitics in clinical medicine XV. Inhibition of coenzyme Q10- enzymes by clinically used adrenergic blockers of beta-receptors. Research Communications in Chemical Pathology and Pharmacology 1977; 17(1): 157-64.
22. Mortensen SA, Leth A, Agner E et al. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Molecular Aspects of Medicine 1997; 18:S137-44.
23. Ghirlands G, Oradei A, Manto A et al. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol 1993; 33(3): 226-29.
24. Chan A, Reichmann H, Kogel A et al. Metabolic Changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy. J Neurol 1998; 245: 681-5.
25. Chen RS, Huang CC, Chu NS. Coenzyme Q10 treatment in mitochondrial encepha-lopathies: short term double-blind, crossover study. Eur Neurol 1997; 37: 212-8.
26. Bresolin N, Doriguzzic, Ponzetto C et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multicenter doubleblind trial. J Neurol Sci 1990; 100: 70-8.
27. Folkers K, Vadhanavikit S, Mortensen SA. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci USA 1985; 82: 901-04.
28. Khatta M, Alexander BS, Krichten CM et al. The effect of coenzyme Q10 in patients with congestive heart failure. 2000; 132(8):636-40.
29. Singh U, Devaraj S, Jialal I. Coenzyme Q10 supplementation and heart failure. 2007; 65(6): 286-93.
30. Jeejeebhoy F, Keith M, Freeman M et al. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J 2002; 143: 1092-100.
31. Judy WV, Stogsdill WVV, Folkers K. Myocardial preservation by therapy with Coenzyme Q10 during heart surgery. Clin Investing 1993; 71 (8 Suppl): S155-61.
32. Rosenfeldt FL, Haas SJ, Krum H et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Human Hyperten 2007; 21(4): 297-306.
33. Huntington Study Group. A randomized placebo-controlled trial of Coenzyme Q10 and remacemide in Huntington's disease. Neurology 2001; 57: 397-404.
34. Rozen TD, Oshinsky ML, Gebeline CA et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia 2002; 22(2): 137-41.
35. Sandor PS, Di Clemente L, Coppola G et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005; 64(4): 713-15.
36. Shults CW, Oakes D, kieburtz K et al. Effects of Coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline. Arch Neurol 2002; 59: 1541-50.
37. Shults CW, Therapeutic role of coenzyme Q(10) in Parkinson's desease. Pharmacol Ther 2005; 107(1): 120-30.
38. Nakamura R, Littarru GP, Folkers K et al. Study of CoQ10-Enzymes in gingiva from patients with periodontal disease and evidence for a deficiency of Coenzyme Q10. Proc Natl Acad Sci USA. 1974; 71(4): 1456-60.
39. Littarru GP, Nakamura R, Ho L et al. Deficiency of Coenzyme Q10 in gingival tissue from patients with periodontal disease. Proc Natl Acad Sci USA 1971; 68(10): 2332-35.
40. McRee JT, Hanioka T, Shizukuishi S et al. Therapy with coenzyme Q10 for patients with periodontal disease. J Dent Health 1993; 43(5): 659-66.
41. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344(8925): 793-95.
42. Parthasarathy S, Steinberg D, Witztum JL, The role of oxidized lowdensity lipoproteins in the pathogenesis of atherosclerosis. Annual Review of Medicine 1992; 43: 219-25.
43. Singh RB, Neki NS, Kartikey K et al. Effect of Coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem 2003; 246: 75-82.
44. Kuettner A, Pieper A, Koch J et al. Influence of Coenzyme Q10 and cerivastatin on the flow-mediated vasodilatation of the brachial artery: results of the ENDOTACT study. Int J Cardiol 2005; 98: 413-19.
45. Damian MS, Ellenberg D, Gildemeister R et al. Coenzyme Q10 combined with mild hypothermia after cardiac arrest: A preliminary study. Circulation 2004; 110(19): 3011-16.
46. Heller FR, Descamps O, Hondekjin JC. LDL oxidation: therapeutic perspectives. Atherosclerosis 1998; 137: S25-31.
47. Sakano K, Takahashi M, Kitano M et al. Suppression of azoxymethane-induced colonic premalignant lesion formation by coenzyme Q10 in rats. Asian Pacific Journal of Cancer Prevention 2006; 7(4): 599-603.
48. Koryagin AS, Krylova EV, Luk'yanova LD. Effect of ubiquinone-10 on the blood system in rats exposed to radiation. Bulletin of Experimental Biology and Medicine 2002; 133(6): 562-64.
49. Mizuno K, Tanaka M et al. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition 2008; 24(4): 293-99.
50. Yubero-Serrano EM, Gonzalez-Guardia L et al. Mediterranean diet supplemented with coenzyme Q10 modifies the expression of proinflammatory and endoplasmic reticulum stress-related genes in elderly men and women. J Gerontol A Biol Sci Med Sci 2012.
51. Hodgson JM,Watts GF, Playford DA et al. Coenzyme Q(10) improves blood pressure and glycaemic control: a Controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 2002; 56: 1137-42.
52. Henriksen JE, Andersen CB, Hother-Nielsen O et al. Impact of ubiquinone (Coenzyme Q10) treatment on glycemic control, insulin requirement and well being in patient with type 1 diabetes mellitus. Diabet Med 1999; 16: 312-18.
53. Caso G, Kelly P, McNurlan MA et al. Effect of coenzyme Q10 on myopathyic symptoms in patients treated with statins. Am J Cardiol 2007; 99(10): 1409-12.
54. Diaz-Castro J, Guisado R et al. Coenzyme Q(10) supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exercise. Eur J Nutr 2011; 123: 6.
55. Teran E, Hernandez I et al. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet 2009; 105(1): 43-5.
56. Quiles J, Ochoa JJ, Huertas JR et al. Coenzyme Q supplementation protects from age-related DNA double-strand breaks and increases lifespan in rats fed on a PUFA-rich diet. Experimental Gerontology 2004; 39(2): 189-94.
57. Coles L, Harris S. Coenzyme Q10 and lifespan extension. Advances in Anti-Aging Medicine 1996; 1(1): 205-15.
58. Fuke C, KriKorian SA, Couris RR, Coenzyme Q10: a review of essential functions and clinical trials. US Pharmacist 2000; 25: 28-41.
59. Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344:1372-73.
60. Engelsen J, Nielsen JD, Hansen KF et al. Effect of coenzyme Q10 and ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebocontrolled cross-over trial (Danish). Ugeskr Laeger 2003; 165: 1868-71.
61. Palan PR, Magneson AT et al. Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants. Am J Obstet Gynecol 2006; 194(5): e35-38.
62. Bleske BE, Willis RA, Antohny M et al. The effect of pravastatin and atorvastatin on coenzyme Q10. Am Heart J 2001; 143: E2.
63. Weis M, Mortensen SA, Rassing MR et al. Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers. Mol Aspects Med 1994; (15suppl): S273-80.